| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.873 | 9.873 | 1 | 7.527 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 19.460 | 10.241 | 37.212 | 106.075 | 31.422 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 18.838 | 9.916 | 37.173 | 105.908 | 10.118 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 622 | 325 | 39 | 166 | 21.304 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 116 | 29 | 39 | 16 | 21.304 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 6 | 3 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Solvagromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.351 | 10.246 | 10.072 | 79.733 | 70.890 | 62.595 | 54.410 | 47.761 | 47.616 | - |
| Current Assets | 19.146 | 18.671 | 39.150 | 47.016 | 950 | 873 | 400 | 183 | 165 | - |
| Inventories | 2.587 | 14.230 | 30.295 | 6.505 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 14.864 | 4.171 | 8.241 | 40.483 | 97 | 95 | 93 | 93 | 93 | - |
| Cash | 1.695 | 271 | 613 | 28 | 854 | 779 | 307 | 90 | 72 | - |
| Shareholders Funds | 18.917 | 18.752 | 18.474 | 18.150 | 39.103 | 38.362 | 37.512 | 37.628 | 37.514 | - |
| Social Capital | 11.249 | 11.134 | 10.945 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 | - |
| Debts | 10.581 | 10.165 | 22.507 | 68.116 | 32.737 | 34.235 | 36.172 | 38.945 | 41.483 | - |
| Income in Advance | 0 | 0 | 8.241 | 40.483 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2020 - 2020" | |||||||||
| CAEN Financial Year |
2020
|
|||||||||
Comments - Solvagromed Srl